cilostazol has been researched along with apyrase in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, M; Ikeda, Y; Kondo, K; Nakashima, M; Saniabadi, AR; Suzuki, Y; Umemura, K | 1 |
| Baek, AE; Kanthi, Y; Liao, H; Pinsky, DJ; Sutton, NR | 1 |
1 trial(s) available for cilostazol and apyrase
| Article | Year |
|---|---|
Adenosine 5'-diphosphate as a factor in platelet aggregation induced by human plasma remnant lipoproteins.
Topics: 2-Chloroadenosine; Adenosine Diphosphate; Adult; Animals; Apyrase; Chylomicrons; Cilostazol; Female; Guinea Pigs; Hematocrit; Humans; In Vitro Techniques; Lipoproteins, VLDL; Male; Mice; Mice, Inbred ICR; Microscopy, Electron, Scanning; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Rabbits; Rats; Rats, Wistar; Tetrazoles | 1998 |
1 other study(ies) available for cilostazol and apyrase
| Article | Year |
|---|---|
Regulation of ecto-apyrase CD39 (ENTPD1) expression by phosphodiesterase III (PDE3).
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine Triphosphatases; Antigens, CD; Apyrase; Cilostazol; Cyclic Nucleotide Phosphodiesterases, Type 3; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Human Umbilical Vein Endothelial Cells; Humans; Macrophages; Milrinone; Tetrazoles; Transcription, Genetic; Ubiquitination | 2013 |